Nitric oxide signaling pathways in the normal and pathological bladder: Do they provide new pharmacological pathways?-ICI-RS 2023.

Chakrabarty, Basu; Winder, Michael; Kanai, Anthony J; Hashitani, Hikaru; Drake, Marcus; Abrams, Paul; Fry, Christopher H.

Affiliation

Chakrabarty B; School of Physiology, Pharmacology & Neuroscience, University of Bristol, Bristol, UK.
Winder M; Department of Pharmacology, University of Gothenburg, Gothenburg, Sweden.
Kanai AJ; Departments of Medicine and Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Hashitani H; Department of Cell Physiology, Nagoya City University, Nagoya, Japan.
Drake M; Department of Surgery and Cancer, Hammersmith Hospital, London, UK.
Abrams P; Bristol Urological Institute, North Bristol NHS Trust, Bristol, UK.
Fry CH; School of Physiology, Pharmacology & Neuroscience, University of Bristol, Bristol, UK.

Neurourol Urodyn ; 2023 Oct 30.

Article in En | MEDLINE | ID: mdl-37902298